,date,title,url
0,2017-10-12,辰欣药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-10-12/603367_20171012_1.pdf
1,2017-10-12,辰欣药业：关于对辰欣药业股份有限公司股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2017-10-12/603367_20171012_2.pdf
2,2017-10-17,辰欣药业及全资子公司关于通过GMP认证的公告,/disclosure/listedinfo/announcement/c/2017-10-17/603367_20171017_9.pdf
3,2017-10-17,辰欣药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-10-17/603367_20171017_7.pdf
4,2017-10-17,辰欣药业：关于对辰欣药业股份有限公司股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2017-10-17/603367_20171017_8.pdf
5,2017-10-20,辰欣药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-10-20/603367_20171020_1.pdf
6,2017-10-25,辰欣药业关于福建省食品药品监督管理局发布的福建省药品质量公告的情况说明,/disclosure/listedinfo/announcement/c/2017-10-25/603367_20171025_1.pdf
7,2017-10-26,辰欣药业关于聚丙烯安瓿包装形式的氯化钾注射液获得延长有效期的公告,/disclosure/listedinfo/announcement/c/2017-10-26/603367_20171026_2.pdf
8,2017-10-26,辰欣药业关于获得1类抗肿瘤药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-10-26/603367_20171026_1.pdf
9,2017-10-27,辰欣药业关于增加设立募集资金专项账户的公告,/disclosure/listedinfo/announcement/c/2017-10-27/603367_20171027_5.pdf
10,2017-10-27,辰欣药业第二届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-27/603367_20171027_4.pdf
11,2017-10-27,辰欣药业第二届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-27/603367_20171027_3.pdf
12,2017-10-27,辰欣药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-27/603367_2017_3.pdf
13,2017-10-28,辰欣药业关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_1.pdf
14,2017-10-28,辰欣药业关于增加经营范围、修订《公司章程》并办理工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_2.pdf
15,2017-10-28,辰欣药业关于选举第三届监事会职工代表监事的公告,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_4.pdf
16,2017-10-28,辰欣药业公司章程,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_3.pdf
17,2017-10-28,辰欣药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_6.pdf
18,2017-10-28,辰欣药业独立董事候选人声明（张宏）,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_9.pdf
19,2017-10-28,辰欣药业独立董事候选人声明（王福清）,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_8.pdf
20,2017-10-28,辰欣药业独立董事候选人声明（孙新生）,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_7.pdf
21,2017-10-28,辰欣药业独立董事关于第二届董事会第十五次会议相关议案的独立意见,/disclosure/listedinfo/announcement/c/2017-10-28/603367_20171028_5.pdf
22,2017-11-01,辰欣药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2017-11-01/603367_20171101_1.pdf
23,2017-11-04,辰欣药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-11-04/603367_20171104_1.pdf
24,2017-11-08,辰欣药业关于河南省食品药品监督管理局发布的河南省药品质量公告的情况说明,/disclosure/listedinfo/announcement/c/2017-11-08/603367_20171108_1.pdf
25,2017-11-21,辰欣药业2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-21/603367_20171121_1.pdf
26,2017-11-25,辰欣药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-11-25/603367_20171125_1.pdf
27,2017-11-25,辰欣药业关于获得盐酸氨溴索口腔崩解片药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-11-25/603367_20171125_2.pdf
28,2017-11-25,辰欣药业关于获得相关荣誉称号的公告,/disclosure/listedinfo/announcement/c/2017-11-25/603367_20171125_3.pdf
29,2017-11-29,辰欣药业关于聘任董事会秘书的公告,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_6.pdf
30,2017-11-29,辰欣药业独立董事关于第三届董事会第一次会议有关议案的独立意见,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_4.pdf
31,2017-11-29,辰欣药业第三届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_5.pdf
32,2017-11-29,辰欣药业第三届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_3.pdf
33,2017-11-29,辰欣药业2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_1.pdf
34,2017-11-29,辰欣药业2017年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-11-29/603367_20171129_2.pdf
35,2017-12-07,辰欣药业关于完成工商登记变更的公告,/disclosure/listedinfo/announcement/c/2017-12-07/603367_20171207_2.pdf
36,2017-12-07,辰欣药业关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-07/603367_20171207_1.pdf
37,2017-12-13,辰欣药业关于获得替硝唑葡萄糖注射液补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-12-13/603367_20171213_1.pdf
38,2017-12-13,辰欣药业关于获得GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-12-13/603367_20171213_2.pdf
39,2017-12-30,辰欣药业关于向参股子公司提供财务资助的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_12.pdf
40,2017-12-30,辰欣药业关于使用暂时闲置的募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_9.pdf
41,2017-12-30,辰欣药业关于使用银行承兑汇票支付募投项目资金并以募集资金等额置换的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_7.pdf
42,2017-12-30,辰欣药业关于使用募集资金置换预先投入募投项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_23.pdf
43,2017-12-30,辰欣药业关于使用部分闲置的自有资金进行现金管理公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_10.pdf
44,2017-12-30,辰欣药业关于认购私募基金份额的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_13.pdf
45,2017-12-30,辰欣药业关于认购私募基金份额的公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_14.pdf
46,2017-12-30,辰欣药业独立董事关于第三届董事会第二次会议有关议案的独立意见,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_2.pdf
47,2017-12-30,辰欣药业第三届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_3.pdf
48,2017-12-30,辰欣药业第三届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_1.pdf
49,2017-12-30,辰欣药业：中泰证券股份有限公司关于辰欣药业股份有限公司使用银行承兑汇票支付募投项目资金并以募集资金等额置换的核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_8.pdf
50,2017-12-30,辰欣药业：中泰证券股份有限公司关于辰欣药业股份有限公司使用闲置募集资金及自有资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_11.pdf
51,2017-12-30,辰欣药业：中泰证券股份有限公司关于辰欣药业股份有限公司使用募集资金置换预先投入募投项目自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_5.pdf
52,2017-12-30,辰欣药业：大信会计师事务所（特殊普通合伙）关于辰欣药业以募集资金置换已投入募集资金项目的自筹资金的审核报告,/disclosure/listedinfo/announcement/c/2017-12-30/603367_20171230_6.pdf
53,2018-01-04,辰欣药业关于使用暂时闲置的募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2018-01-04/603367_20180104_1.pdf
54,2018-01-04,辰欣药业关于使用部分闲置的自有资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2018-01-04/603367_20180104_2.pdf
55,2018-01-04,辰欣药业关于获得盐酸右美托咪定注射液增加适应症药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2018-01-04/603367_20180104_3.pdf
56,2018-01-04,辰欣药业关于获得盐酸托烷司琼注射液药品药品注册批件的公告,/disclosure/listedinfo/announcement/c/2018-01-04/603367_20180104_4.pdf
57,2018-01-09,辰欣药业关于使用暂时闲置的募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2018-01-09/603367_20180109_1.pdf
58,2018-01-12,辰欣药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2018-01-12/603367_20180112_1.pdf
59,2018-02-09,辰欣药业关于使用部分闲置的自有资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2018-02-09/603367_20180209_1.pdf
